首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING MESENCHYMAL STEM CELL EXPRESSING TRAIL AND CD AS ACTIVE INGREDIENT

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING MESENCHYMAL STEM CELL EXPRESSING TRAIL AND CD AS ACTIVE INGREDIENT

机译:预防或治疗间质干细胞表达轨迹和CD为有效成分的癌症的药物组合物

摘要

The present invention relates to a pharmaceutical composition for preventing or treating cancer which comprises a mesenchymal stem cell which expresses TRAIL and CD as an active ingredient. A pharmaceutical composition for preventing or treating cancer which comprises a mesenchymal stem cell which expresses TRAIL and CD as an active ingredient prevents formation and metastasis of cancer cells by inducing apoptosis of the cancer cells. Additionally, the mesenchymal stem cell is an immortalized mesenchymal stem cell, has high cell proliferation and can adjust expression of TRAIL protein and CD protein in a cell depending on processing doxycycline. As a result, abnormal differentiation possibility by continuous expression of an introduced gene is low, and a surviving stem cell can be removed by apoptosis which is induced by a 5-FC process, and thus stability is high. Moreover, an anticancer effect of a cell line for expressing TRAIL and CD at the same time is excellent, and thus a pharmaceutical composition of the present invention can be useful for preventing and treating cancer.;COPYRIGHT KIPO 2019
机译:本发明涉及一种用于预防或治疗癌症的药物组合物,其包含表达TRAIL和CD作为活性成分的间充质干细胞。包含表达TRAIL和CD的间充质干细胞作为有效成分的预防或治疗癌症的药物组合物通过诱导癌细胞的凋亡来防止癌细胞的形成和转移。另外,间充质干细胞是永生化的间充质干细胞,具有高细胞增殖能力,并且可以根据加工强力霉素来调节细胞中TRAIL蛋白和CD蛋白的表达。结果,通过导入的基因的连续表达引起的异常分化可能性低,并且可以通过5-FC过程诱导的细胞凋亡去除存活的干细胞,因此稳定性高。此外,同时表达TRAIL和CD的细胞系的抗癌作用极好,因此本发明的药物组合物可用于预防和治疗癌症。; COPYRIGHT KIPO 2019

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号